Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.

Abstract

Patients with type 2 diabetes mellitus are at 2 to 4 times increased risk of cardiovascular events compared with those without diabetes, both among patients with multiple risk factors only and those with established atherothrombosis. In this review, we provide recommendations for the use of statins and aspirin for the prevention of cardiovascular events in high-risk patients with diabetes mellitus.

• Authors: Jacob A Udell, Benjamin M Scirica, Eugene Braunwald, Itamar Raz, Ph Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Deepak L Bhatt
• Journal: Clinical cardiology (Clin Cardiol) Vol. 35 Issue 12 Pg. 722-9 (Dec 2012) ISSN: 1932-8737 [Electronic] United States
• PMID: 22760763 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: © 2012 Wiley Periodicals, Inc.

Chemical References

• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Aspirin

Topics

• Aspirin (therapeutic use)
• Cardiovascular Diseases (prevention & control)
• Diabetes Mellitus, Type 2 (complications)
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
• Practice Guidelines as Topic